ORIGINAL RESEARCH
Published on 16 Apr 2025
Leveraging a disulfidptosis-based signature to characterize heterogeneity and optimize treatment in multiple myeloma
doi 10.3389/fimmu.2025.1559317
- 183 views
673
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: